Loading
Travere Therapeutics
  • Home
  • Be Kind to your Kidneys
  • Careers
  • Transition
  • Revised Pipeline Animated Graphic
  • Editable Therapeutic Areas
  • Senior Leadership
    • Chris Cline
    • Peter Heerma
    • Eric Dube, Ph.D.
    • Laura M. Clague, CPA
    • Noah L. Rosenberg, M.D.
    • Jula Inrig, M.D.
    • Laura M. Johnson
    • Casey Logan
    • William Rote, Ph.D.
    • Elizabeth Reed, J.D.
  • Medical Education Grants
  • About Us
    • COVID-19
  • Our Culture
    • Equity, Diversity & Inclusion
    • Our Why
  • Privacy
    • Individual Rights Request Form
      • Thank you
    • California Privacy Policy
    • Clinical Trials Privacy Policy
    • Website Cookies Policy
    • Corporate Privacy Policy
  • Patient Advocacy
  • Diagnostic Testing Programs
  • INVESTIGATOR-SPONSORED RESEARCH
  • Contact Us
  • Thank You for Contacting Us
  • Our Pipeline
    • TVT-058
    • ALGS COLLABORATION
    • Sparsentan for IgAN
    • Sparsentan for FSGS
    • Chenodeoxycholic Acid (CDCA) Program
    • NGLY1 Collaboration
    • Clinical Trials
  • Our Therapies
  • Board of Directors
    • Suzanne L. Bruhn, Ph.D.
    • Sandra E. Poole
    • Gary A. Lyons
    • Ruth Williams-Brinkley
    • Roy D. Baynes, M.D., Ph.D.
    • Tim Coughlin, CPA
    • Jeffrey A. Meckler
    • John A. Orwin
    • Ron Squarer
  • Pathfinder
  • Expanded Access
  • Terms & Conditions
  • Community Guidelines
  • Patients & Caregivers
  • Therapeutic Areas
    • Classical Homocystinuria (HCU)
    • ALAGILLE SYNDROME (ALGS)
    • IgA NEPHROPATHY (IgAN)
    • N-GLYCANASE 1 (NGLY1) DEFICIENCY
    • FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    • CYSTINURIA
    • CEREBROTENDINOUS XANTHOMATOSIS (CTX)
    • PEROXISOME BIOGENESIS DISORDER-ZELLWEGER SPECTRUM DISORDER (PBD-ZSD)
    • BILE ACID SYNTHESIS DISORDERS (BASD)
  • Search
  • Menu Menu
You are here: Home1 / Rare Life2 / Matthew

Meet Matthew

Composer

“Matthew learned very early to set life goals. He has goals in communication, in music, in education, in writing, and he keeps himself focused on what he wants to do. He told me, ‘Mom, I have just a short time and I don’t want to waste what I have.’ And so he feels focused and also pressured because he understands the disease is progressive – and as time goes on he might be doing less and less. But he’s already accomplished more in his life than I have in mine, and I’m three times his age. I’m so proud of him.”  —Joyce, Matthew’s mother

RET146

PATHFINDER

  • All
  • News
  • Rare Life
  • Press Releases

© 2022 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.

Terms and Conditions | Privacy Policies | Cookie Settings

Follow a manual added link

Scroll to top